| Name | Title | Contact Details |
|---|---|---|
Wayne Farbman |
Associate Director, Clinical R&D Systems | Profile |
Barry Anderson |
Vice President, Clinical Research Development | Profile |
Travanti Pharma is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
4 dry skin natural products is a Nashville, KY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Abraxis Oncology is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
arGentis™ Pharmaceuticals, LLC is a private TN based pharmaceutical company with a mid-stage Orphan Drug treatment (ARG201) for late stage diffuse systemic scleroderma (dcSSc). The company is seeking capital or a partner to complete a Pivotal Clinical Trial which will enable obtaining marketing approval in the EU. The Company has a genotype marker (ROT1) that predicts patient response to treatment by oral tolerance for treatments like ARG201 for dcSSc. Furthermore, arGentis™ has a treatment for Rheumatoid arthritis (ARG301) that is in a Phase I Clinical Trial in the US.